Home > Insider Trading > Filing (0001562180-21-002171)

Filing Details

Accession Number:: 0001562180-21-002171
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-03-11 14:48:53
Reporting Period:: 2021-03-09

Accepted Time:: 2021-03-11 14:48:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1531048	Inari Medical Inc.	NARI	Surgical & Medical Instruments & Apparatus (3841)	452902923

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1644989	Hill, Mitch C.	C/O Inari Medical, Inc. 9 Parker, Suite 100 Irvine CA 92618	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-03-09	5,000	$0.46	73,190	No	4	M	Direct
Common Stock	Disposition	2021-03-09	100	$94.05	73,090	No	4	S	Direct
Common Stock	Disposition	2021-03-09	400	$95.53	72,690	No	4	S	Direct
Common Stock	Disposition	2021-03-09	1,500	$97.44	71,190	No	4	S	Direct
Common Stock	Disposition	2021-03-09	2,058	$98.39	69,132	No	4	S	Direct
Common Stock	Disposition	2021-03-09	942	$99.28	68,190	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to buy)	Disposition	2021-03-09	5,000	$0.00	5,000	$0.46

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
311,977		2029-04-30	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,600	Indirect	By Spouse

Footnotes

Includes 347 shares acquired under the Employee Stock Purchase Plan.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2020
This transaction was executed in multiple trades at prices ranging from $95.25 to $95.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $96.90 to $97.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $97.91 to $98.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $98.93 to $99.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Option vested with respect to 25% of the underlying shares on April 30, 2020 and vests with respect to the remaining shares in 36 equal monthly installment thereafter.